Summary GLP-1 receptor agonists have four main characteristics: strong hypoglycemic effect, weight loss, lower incidence of hypoglycemia than other hypoglycemic agents, and more cardiovascular benefits
It can be beneficial for a wide range of conditions, including chronic infections, autoimmune diseases, arthritis, cardiovascular conditions, and more
If a veterinarian is already using GHK-Cu in practice, they can usually direct pet owners to trusted suppliers
Kariya Pharmaceuticals has taken a unique approach with KP405, a first-in-class dual GLP-1/GIP receptor agonist with the potential to synergistically reduce neuroinflammation, enhance mitochondrial function and support neuronal survival
Contact your healthcare professional promptly if side effects are severe, persistent, or worrying for example, severe abdominal pain, persistent vomiting, or any symptoms that concern you
Bakal, Y